Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Monte Rosa Therapeutics, Inc. (GLUE)
USD23.33
+1.35 (+6.12%)
US NASDAQ Healthcare Biotechnology
Address
645 Summer Street 2210
Boston, MA, US
Boston, MA, US
CEO
Markus Warmuth
Website
monterosatx.com
IPO
2021-06-24
CIK 1826457 ISIN US61225M1027
Description
Monte Rosa Therapeutics, Inc. is a biopharmaceutical company dedicated to pioneering novel, small-molecule precision medicines. Their core approach involves leveraging the body's inherent mechanisms to precisely eliminate therapeutically relevant proteins. Among their key initiatives is an oral molecular glue degrader designed to target GSPT1, a specific translational termination factor and degron-containing protein, with the aim of treating Myc-driven cancers. The company's pipeline further includes programs for CDK2 in ovarian, uterine, and breast cancers, alongside NEK7 for addressing a spectrum of inflammatory conditions such as Crohn's disease, neurodegenerative ailments, diabetes, and liver disease. Moreover, VAV1 is being explored as a target for autoimmune disorders, and BCL11A, a protein holding significant therapeutic relevance, is under investigation for hemoglobinopathies. Founded in 2019, Monte Rosa Therapeutics, Inc. operates from its headquarters in Boston, Massachusetts.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD23.33
+1.35 (+6.12%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
1M
Beta
1.60
Float Shares
42.14M
Free Float %
64.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -5.68% | -5.63% | +9.32% | +3.30% | +34.96% | +21.88% | +347.54% | +236.44% | -9.77% | -9.77% | -9.77% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
23.33
Low
22.00
-5.7%
Consensus
31.75
+36.1%
Median
34.00
+45.8%
High
37.00
+58.6%
DCF (Unlevered)
24.06
+3.1%
DCF (Levered)
19.36
-17.0%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 6 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | 5 |
29.80
+27.8%
|
| All Time | 5 |
29.80
+27.8%
|
Quality scores
Altman Z-Score
2.91
Grey zone
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
3 / 5
Medium
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+63.5% ★ Q1'26: -95.0% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+53.1% ★ Q1'26: -219.3% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-47.4% Q1'26: -932.0% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-43.8% Q1'26: -1,188.5% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +190.2% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+12.4% Q1'26: -21.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.85× Q1'26: -0.20× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 5 Rev. Ana. 4 EPS Ana. |
Dec 2027 5 Rev. Ana. 5 EPS Ana. |
Dec 2028 5 Rev. Ana. 5 EPS Ana. |
Dec 2029 2 Rev. Ana. 1 EPS Ana. |
Dec 2030 2 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|
| Revenue |
—
est: 1.06M (-100.0%)
|
75.62M
est: 59.79M (+26.5%)
|
123.67M
est: 136.47M (-9.4%)
|
44.46M
14.46M – 95.19M
-67.4% YoY
|
58.21M
19.07M – 136.49M
+30.9% YoY
|
22.25M
7.27M – 50.26M
-61.8% YoY
|
115.14M
37.61M – 260.09M
+417.5% YoY
|
173.87M
56.80M – 392.75M
+51.0% YoY
|
| EBITDA |
-137.09M
est: 354.1K (-38,814.1%)
|
-72.99M
est: 19.90M (-466.8%)
|
-45.85M
est: 45.42M (-201.0%)
|
14.80M
4.81M – 31.68M
-67.4% YoY
|
19.37M
6.35M – 45.42M
+30.9% YoY
|
7.40M
2.42M – 16.73M
-61.8% YoY
|
38.32M
12.52M – 86.56M
+417.5% YoY
|
57.86M
18.90M – 130.71M
+51.0% YoY
|
| EBIT |
-143.31M
est: 332.3K (-43,223.7%)
|
-81.11M
est: 18.67M (-534.4%)
|
-54.21M
est: 42.62M (-227.2%)
|
13.89M
4.52M – 29.73M
-67.4% YoY
|
18.18M
5.96M – 42.63M
+30.9% YoY
|
6.95M
2.27M – 15.70M
-61.8% YoY
|
35.96M
11.75M – 81.23M
+417.5% YoY
|
54.31M
17.74M – 122.67M
+51.0% YoY
|
| Net Income |
-135.35M
est: -135.28M (-0.1%)
|
-72.70M
est: -105.29M (+31.0%)
|
-38.63M
est: -21.42M (-80.3%)
|
-163.79M
-204.73M – -14.45M
-664.6% YoY
|
-180.46M
-260.97M – 65.90M
-10.2% YoY
|
-230.16M
-268.27M – -52.73M
-27.5% YoY
|
-175.28M
-462.13M – -21.85M
+23.8% YoY
|
-131.09M
-345.61M – -16.34M
+25.2% YoY
|
| SGA |
32.04M
est: 800.0K (+3,905.0%)
|
35.17M
est: 44.95M (-21.8%)
|
36.38M
est: 102.60M (-64.5%)
|
33.42M
10.88M – 71.57M
-67.4% YoY
|
43.77M
14.34M – 102.62M
+30.9% YoY
|
16.73M
5.46M – 37.79M
-61.8% YoY
|
86.57M
28.28M – 195.55M
+417.5% YoY
|
130.72M
42.70M – 295.29M
+51.0% YoY
|
| EPS |
-2.63
est: -2.50 (-5.2%)
|
-0.98
est: -1.25 (+21.9%)
|
-0.46
est: -0.26 (-78.4%)
|
-1.64
-2.46 – -0.17
-535.2% YoY
|
-1.82
-3.14 – 0.79
-11.4% YoY
|
-2.29
-3.23 – -0.63
-25.7% YoY
|
-2.11
-5.56 – -0.26
+8.0% YoY
|
-1.58
-4.16 – -0.20
+25.2% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-07 | C | 2/5 | 4/5 | 1/5 | 1/5 | 3/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-05 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-04 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-05-01 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-30 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-29 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-28 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-27 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-24 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-23 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-22 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-21 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-20 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-17 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-16 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
| 2026-04-15 | C | 2/5 | 4/5 | 1/5 | 1/5 | 2/5 | 1/5 | 2/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
32.56M
OE per share TTM
0.02
Owner's Yield
2.51%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
125.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
26
Total invested
6.28M
Insider transactions (90d)
1
Beneficial owners (>5%)
29
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Ali Behbahani | 7.69M | 17.30% | 2.6K | 7.69M | 2.6K | 7.69M | IN | States | 2021-07-12 | ↗ |
| 2 | Baskett | 7.69M | 17.30% | — | 7.69M | — | 7.69M | IN | States | 2021-07-12 | ↗ |
| 3 | D. Sandell | 7.69M | 17.30% | — | 7.69M | — | 7.69M | IN | States | 2021-07-12 | ↗ |
| 4 | Edward T. Mathers | 7.69M | 17.30% | — | 7.69M | — | 7.69M | IN | States | 2021-07-12 | ↗ |
| 5 | H. Makhzoumi | 7.69M | 17.30% | — | 7.69M | — | 7.69M | IN | States | 2021-07-12 | ↗ |
| 6 | Joshua Makower | 7.69M | 17.30% | — | 7.69M | — | 7.69M | IN | States | 2021-07-12 | ↗ |
| 7 | NEA Partners 17, L.P. | 7.69M | 17.30% | — | 7.69M | — | 7.69M | PN | Delaware Limited Partnership | 2021-07-12 | ↗ |
| 8 | New Enterprise Associates 17, L.P. | 7.69M | 17.30% | — | 7.69M | — | 7.69M | PN | — | 2021-07-12 | ↗ |
| 9 | Peter W. Sonsini | 7.69M | 17.30% | — | 7.69M | — | 7.69M | IN | States | 2021-07-12 | ↗ |
| 10 | Rick Yang | 7.69M | 17.30% | — | 7.69M | — | 7.69M | IN | — | 2021-07-12 | ↗ |
| 11 | Walker | 7.69M | 17.30% | — | 7.69M | — | 7.69M | IN | States | 2021-07-12 | ↗ |
| 12 | Abigail P. Johnson | 6.17M | 13.87% | — | — | 6.17M | — | IN | Delaware | 2021-08-10 | ↗ |
| 13 | FMR LLC | 6.17M | 13.87% | 1.31M | — | 6.17M | — | HC | Delaware | 2021-08-10 | ↗ |
| 14 | Baker Bros. Advisors (GP) LLC | 4.92M | 9.80% | 4.92M | — | 4.92M | — | HC, OO | Delaware | 2024-02-14 | ↗ |
| 15 | Baker Bros. Advisors LP | 4.92M | 9.80% | 4.92M | — | 4.92M | — | IA, PN | Delaware | 2024-02-14 | ↗ |
| 16 | Felix J. Baker | 4.92M | 9.80% | 4.92M | — | 4.92M | — | HC, IN | Delaware | 2024-02-14 | ↗ |
| 17 | Julian C. Baker | 4.92M | 9.80% | 4.92M | — | 4.92M | — | HC, IN | Delaware | 2024-02-14 | ↗ |
| 18 | 52-0556948 | 4.15M | 8.90% | 767.0K | — | 4.15M | — | IA | Maryland | 2022-02-10 | ↗ |
| 19 | (1) BlackRock, Inc. | 3.60M | 7.40% | 3.54M | — | 3.60M | — | HC | Delaware | 2023-02-03 | ↗ |
| 20 | Avoro Capital Advisors LLC | 3.31M | 7.10% | 3.31M | — | 3.31M | — | IA, OO | — | 2022-02-11 | ↗ |
| 21 | Behzad Aghazadeh | 3.31M | 7.10% | 3.31M | — | 3.31M | — | IN | — | 2022-02-11 | ↗ |
| 22 | Bihua Chen | 3.00M | 6.46% | — | 3.00M | — | — | IN | — | 2022-02-14 | ↗ |
| 23 | Cormorant Asset Management, LP | 3.00M | 6.46% | — | 3.00M | — | — | PN | — | 2022-02-14 | ↗ |
| 24 | Cormorant Private Healthcare Fund III, LP | 1.42M | 3.05% | — | 1.42M | — | — | PN | — | 2022-02-14 | ↗ |
| 25 | Cormorant Private Healthcare GP III, LLC | 1.42M | 3.05% | — | 1.42M | — | — | OO | — | 2022-02-14 | ↗ |
| 26 | Cormorant Private Healthcare Fund II, LP | 843.6K | 1.81% | — | 843.6K | — | — | PN | — | 2022-02-14 | ↗ |
| 27 | Cormorant Private Healthcare GP II, LLC | 843.6K | 1.81% | — | 843.6K | — | — | OO | — | 2022-02-14 | ↗ |
| 28 | Cormorant Global Healthcare GP, LLC | 730.9K | 1.57% | — | 730.9K | — | — | OO | Delaware | 2022-02-14 | ↗ |
| 29 | Cormorant Global Healthcare Master Fund, LP | 730.9K | 1.57% | — | 730.9K | — | — | PN | — | 2022-02-14 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
26
-140 vs prev Q
New positions
7
Closed positions
140
Increased
16
Reduced
8
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | MACQUARIE MANAGEMENT HOLDINGS, INC. | 200.0K +200.0K (+100.0%) | 3.14B +3.1B (+100.0%) | 0.24% +0.243 pp | 0.00% +0.005 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 2 | NEA MANAGEMENT COMPANY, LLC | 7.69M +— (+0.0%) | 120.62M +63.6M (+111.6%) | 9.34% -0.024 pp | 6.15% +3.022 pp | USD22.70 -30.9% | 19 qtrs — |
| 3 | PRICE T ROWE ASSOCIATES INC /MD/ | 5.12M +481.8K (+10.4%) | 80.27M +45.9M (+133.6%) | 6.21% +0.570 pp | 0.01% +0.005 pp | USD13.34 +17.5% | 19 qtrs — |
| 4 | TCG CROSSOVER MANAGEMENT, LLC | 4.62M +4.6M (+100.0%) | 72.48M +72.5M (+100.0%) | 5.61% +5.610 pp | 2.40% +2.399 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 5 | VERSANT VENTURE MANAGEMENT, LLC | 4.38M -1.3M (-22.5%) | 68.72M +26.8M (+64.1%) | 5.32% -1.559 pp | 45.49% +25.776 pp | USD6.94 +125.9% | 5 qtrs — |
| 6 | BAKER BROS. ADVISORS LP | 4.35M -570.4K (-11.6%) | 68.14M +31.7M (+87.1%) | 5.27% -0.708 pp | 0.40% +0.136 pp | USD6.13 +155.8% | 12 qtrs — |
| 7 | BLACKROCK, INC. | 4.18M +366.0K (+9.6%) | 65.56M +37.3M (+131.9%) | 5.07% +0.432 pp | 0.00% +0.001 pp | USD6.55 +139.4% | 6 qtrs — |
| 8 | BVF INC/IL | 3.84M -1.8M (-32.2%) | 60.15M +18.2M (+43.4%) | 4.66% -2.232 pp | 2.02% +0.325 pp | USD5.76 +172.2% | 5 qtrs — |
| 9 | SUVRETTA CAPITAL MANAGEMENT, LLC | 3.36M +— (+0.0%) | 52.68M +27.8M (+111.6%) | 4.08% -0.011 pp | 1.08% +0.442 pp | USD4.24 +269.8% | 7 qtrs — |
| 10 | VANGUARD GROUP INC | 3.25M +257.5K (+8.6%) | 50.91M +28.8M (+129.8%) | 3.94% +0.303 pp | 0.00% +0.000 pp | USD10.73 +46.1% | 19 qtrs — |
| 11 | STATE STREET CORP | 2.11M +1.3M (+148.9%) | 33.05M +26.8M (+426.7%) | 2.56% +1.527 pp | 0.00% +0.001 pp | USD13.61 +15.2% | 18 qtrs — |
| 12 | AISLING CAPITAL MANAGEMENT LP | 1.47M +— (+0.0%) | 23.09M +12.2M (+111.6%) | 1.79% -0.005 pp | 4.82% +2.430 pp | USD22.70 -30.9% | 19 qtrs — |
| 13 | AMERICAN CENTURY COMPANIES INC | 1.33M +736.2K (+124.1%) | 20.85M +16.5M (+374.1%) | 1.61% +0.892 pp | 0.01% +0.008 pp | USD11.19 +40.1% | 11 qtrs — |
| 14 | FMR LLC | 1.30M -1.5M (-53.8%) | 20.39M -453.3K (-2.2%) | 1.58% -1.844 pp | 0.00% +0.000 pp | USD18.07 -13.2% | 19 qtrs — |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 1.20M +53.3K (+4.6%) | 18.90M +10.4M (+121.4%) | 1.46% +0.061 pp | 0.00% +0.001 pp | USD10.11 +55.1% | 18 qtrs — |
| 16 | BIOIMPACT CAPITAL LLC | 1.17M +1.2M (+100.0%) | 18.40M +18.4M (+100.0%) | 1.42% +1.424 pp | 2.11% +2.105 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 17 | SILVERARC CAPITAL MANAGEMENT, LLC | 1.03M +334.1K (+48.1%) | 16.14M +11.0M (+213.3%) | 1.25% +0.403 pp | 2.24% +1.547 pp | USD10.10 +55.2% | 2 qtrs — |
| 18 | BRAIDWELL LP | 948.3K +948.3K (+100.0%) | 14.87M +14.9M (+100.0%) | 1.15% +1.151 pp | 0.48% +0.476 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 19 | MORGAN STANLEY | 805.5K +160.3K (+24.9%) | 12.63M +7.8M (+164.2%) | 0.98% +0.193 pp | 0.00% +0.001 pp | USD8.30 +88.9% | 18 qtrs — |
| 20 | AQR CAPITAL MANAGEMENT LLC | 785.1K +67.8K (+9.5%) | 12.31M +7.0M (+131.6%) | 0.95% +0.080 pp | 0.01% +0.003 pp | USD5.50 +185.1% | 4 qtrs — |
| 21 | VESTAL POINT CAPITAL, LP | 775.0K -25.0K (-3.1%) | 12.15M +6.2M (+105.0%) | 0.94% -0.033 pp | 0.41% +0.146 pp | USD7.41 +111.6% | 2 qtrs — |
| 22 | ALPHABET INC. | 744.9K -719.1K (-49.1%) | 11.68M +832.4K (+7.7%) | 0.90% -0.877 pp | 0.45% +0.002 pp | USD22.70 -30.9% | 19 qtrs — |
| 23 | PARKWOOD LLC | 708.0K +— (+0.0%) | 11.10M +5.9M (+111.6%) | 0.86% -0.002 pp | 0.86% +0.382 pp | USD4.94 +217.4% | 6 qtrs — |
| 24 | NORTHERN TRUST CORP | 697.0K -43.7K (-5.9%) | 10.93M +5.4M (+99.1%) | 0.85% -0.055 pp | 0.00% +0.001 pp | USD7.55 +107.7% | 18 qtrs — |
| 25 | DIMENSIONAL FUND ADVISORS LP | 568.4K -63.8K (-10.1%) | 8.91M +4.2M (+90.3%) | 0.69% -0.079 pp | 0.00% +0.001 pp | USD5.63 +178.5% | 12 qtrs — |
| 26 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | 523.4K +164.5K (+45.8%) | 8.21M +5.5M (+208.6%) | 0.64% +0.199 pp | 0.17% +0.115 pp | USD8.51 +84.3% | 3 qtrs — |
| 27 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 448.7K +65.4K (+17.1%) | 7.04M +4.2M (+147.7%) | 0.54% +0.078 pp | 0.00% +0.001 pp | USD10.98 +42.8% | 18 qtrs — |
| 28 | MARSHALL WACE, LLP | 398.9K -503.9K (-55.8%) | 6.25M -435.4K (-6.5%) | 0.48% -0.614 pp | 0.01% -0.001 pp | USD6.74 +132.6% | 6 qtrs — |
| 29 | INVESCO LTD. | 362.2K +264.3K (+270.0%) | 5.68M +5.0M (+682.9%) | 0.44% +0.321 pp | 0.00% +0.001 pp | USD13.02 +20.4% | 5 qtrs — |
| 30 | ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 307.7K +307.7K (+100.0%) | 4.82M +4.8M (+100.0%) | 0.37% +0.373 pp | 0.00% +0.003 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 31 | GOLDMAN SACHS GROUP INC | 295.9K +194.7K (+192.5%) | 4.64M +3.9M (+519.0%) | 0.36% +0.236 pp | 0.00% +0.001 pp | USD12.01 +30.6% | 19 qtrs — |
| 32 | NUVEEN, LLC | 285.9K +182.9K (+177.6%) | 4.48M +3.7M (+487.5%) | 0.35% +0.222 pp | 0.00% +0.001 pp | USD11.70 +34.0% | 4 qtrs — |
| 33 | NEXTECH INVEST, LTD. | 279.2K +279.2K (+100.0%) | 4.38M +4.4M (+100.0%) | 0.34% +0.339 pp | 0.42% +0.423 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 34 | EMPOWERED FUNDS, LLC | 278.1K +190.6K (+218.0%) | 4.36M +3.7M (+572.9%) | 0.34% +0.231 pp | 0.03% +0.028 pp | USD13.08 +19.9% | 2 qtrs — |
| 35 | ACADIAN ASSET MANAGEMENT LLC | 247.9K +44.3K (+21.8%) | 3.88M +2.4M (+157.7%) | 0.30% +0.053 pp | 0.01% +0.004 pp | USD8.36 +87.6% | 9 qtrs — |
| 36 | BANK OF AMERICA CORP /DE/ | 223.6K -46.1K (-17.1%) | 3.51M +1.5M (+75.5%) | 0.27% -0.057 pp | 0.00% +0.000 pp | USD5.22 +200.4% | 18 qtrs — |
| 37 | ADAR1 CAPITAL MANAGEMENT, LLC | 215.8K +— (+0.0%) | 3.38M +1.8M (+111.6%) | 0.26% -0.001 pp | 0.25% +0.098 pp | USD7.41 +111.6% | 2 qtrs — |
| 38 | TD ASSET MANAGEMENT INC | 213.5K +41.4K (+24.1%) | 3.35M +2.1M (+162.5%) | 0.26% +0.050 pp | 0.00% +0.002 pp | USD13.88 +13.0% | 19 qtrs — |
| 39 | BANK OF NEW YORK MELLON CORP | 173.3K -13.5K (-7.2%) | 2.72M +1.3M (+96.3%) | 0.21% -0.017 pp | 0.00% +0.000 pp | USD9.70 +61.6% | 18 qtrs — |
| 40 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 162.7K -9.3K (-5.4%) | 2.55M +1.3M (+100.2%) | 0.20% -0.012 pp | 0.00% +0.000 pp | USD7.41 +111.6% | 2 qtrs — |
| 41 | TREXQUANT INVESTMENT LP | 149.7K +149.7K (+100.0%) | 2.35M +2.3M (+100.0%) | 0.18% +0.182 pp | 0.02% +0.021 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 42 | WELLINGTON MANAGEMENT GROUP LLP | 148.1K -10.5K (-6.6%) | 2.32M +1.1M (+97.6%) | 0.18% -0.013 pp | 0.00% +0.000 pp | USD5.80 +170.3% | 8 qtrs — |
| 43 | ATOM INVESTORS LP | 137.3K +137.3K (+100.0%) | 2.15M +2.2M (+100.0%) | 0.17% +0.167 pp | 0.17% +0.171 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 44 | JANE STREET GROUP, LLC | 137.0K -170.0K (-55.4%) | 2.15M -126.3K (-5.6%) | 0.17% -0.207 pp | 0.00% +0.000 pp | USD7.41 +111.6% | 2 qtrs — |
| 45 | MANUFACTURERS LIFE INSURANCE COMPANY, THE | 134.7K +16.3K (+13.8%) | 2.15M +1.3M (+144.7%) | 0.16% +0.019 pp | 0.00% +0.001 pp | USD12.65 +24.0% | 16 qtrs — |
| 46 | BARCLAYS PLC | 136.0K +81.5K (+149.5%) | 2.13M +1.8M (+638.1%) | 0.17% +0.099 pp | 0.00% +0.000 pp | USD11.48 +36.6% | 16 qtrs — |
| 47 | J. GOLDMAN & CO LP | 135.0K +135.0K (+100.0%) | 2.12M +2.1M (+100.0%) | 0.16% +0.164 pp | 0.06% +0.056 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 48 | UBS GROUP AG | 123.0K +50.9K (+70.6%) | 1.93M +1.4M (+261.0%) | 0.15% +0.062 pp | 0.00% +0.000 pp | USD9.88 +58.7% | 13 qtrs — |
| 49 | AMERIPRISE FINANCIAL INC | 122.2K +122.2K (+100.0%) | 1.92M +1.9M (+100.0%) | 0.15% +0.148 pp | 0.00% +0.000 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 50 | MILLENNIUM MANAGEMENT LLC | 104.0K -341.0K (-76.6%) | 1.63M -1.7M (-50.6%) | 0.13% -0.415 pp | 0.00% -0.001 pp | USD7.04 +122.7% | 9 qtrs — |
| 51 | CAMPBELL & CO INVESTMENT ADVISER LLC | 90.8K +39.6K (+77.5%) | 1.42M +1.0M (+275.6%) | 0.11% +0.048 pp | 0.07% +0.040 pp | USD11.02 +42.3% | 2 qtrs — |
| 52 | IEQ CAPITAL, LLC | 89.3K +30.2K (+51.1%) | 1.40M +962.0K (+219.8%) | 0.11% +0.037 pp | 0.00% +0.003 pp | USD8.29 +89.1% | 3 qtrs — |
| 53 | CASDIN CAPITAL, LLC | 86.0K +— (+0.0%) | 1.35M +711.3K (+111.6%) | 0.10% 0.000 pp | 0.08% +0.031 pp | USD22.70 -30.9% | 19 qtrs — |
| 54 | D. E. SHAW & CO., INC. | 85.5K +35.3K (+70.3%) | 1.34M +968.4K (+260.3%) | 0.10% +0.043 pp | 0.00% +0.001 pp | USD10.82 +44.9% | 2 qtrs — |
| 55 | FRANKLIN RESOURCES INC | 85.2K +41.8K (+96.3%) | 1.34M +1.0M (+315.4%) | 0.10% +0.051 pp | 0.00% +0.000 pp | USD10.38 +51.1% | 5 qtrs — |
| 56 | EAM INVESTORS, LLC | 70.0K +70.0K (+100.0%) | 1.10M +1.1M (+100.0%) | 0.09% +0.085 pp | 0.12% +0.122 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 57 | CANADA PENSION PLAN INVESTMENT BOARD | 68.1K +68.1K (+100.0%) | 1.07M +1.1M (+100.0%) | 0.08% +0.083 pp | 0.00% +0.001 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 58 | RANGELEY CAPITAL, LLC | 67.5K -45.5K (-40.3%) | 1.06M +221.1K (+26.4%) | 0.08% -0.056 pp | 0.88% +0.155 pp | USD7.41 +111.6% | 2 qtrs — |
| 59 | RAFFERTY ASSET MANAGEMENT, LLC | 67.4K +67.4K (+100.0%) | 1.06M +1.1M (+100.0%) | 0.08% +0.082 pp | 0.00% +0.004 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 60 | ALLIANCEBERNSTEIN L.P. | 63.5K +— (+0.0%) | 995.4K +525.0K (+111.6%) | 0.08% 0.000 pp | 0.00% +0.000 pp | USD5.44 +188.2% | 13 qtrs — |
| 61 | ADVISORY RESEARCH INC | 63.2K +63.2K (+100.0%) | 991.3K +991.3K (+100.0%) | 0.08% +0.077 pp | 0.12% +0.125 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 62 | DIADEMA PARTNERS LP | 62.3K +62.3K (+100.0%) | 976.6K +976.6K (+100.0%) | 0.08% +0.076 pp | 0.17% +0.168 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 63 | RHUMBLINE ADVISERS | 61.9K -2.1K (-3.3%) | 969.9K +496.1K (+104.7%) | 0.08% -0.003 pp | 0.00% +0.000 pp | USD10.04 +56.2% | 18 qtrs — |
| 64 | STEMPOINT CAPITAL LP | 61.6K +61.6K (+100.0%) | 965.5K +965.5K (+100.0%) | 0.07% +0.075 pp | 0.17% +0.166 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 65 | SEI INVESTMENTS CO | 59.7K +43.3K (+263.7%) | 935.6K +814.0K (+669.7%) | 0.07% +0.053 pp | 0.00% +0.001 pp | USD13.27 +18.2% | 5 qtrs — |
| 66 | NANTAHALA CAPITAL MANAGEMENT, LLC | 58.0K +58.0K (+100.0%) | 909.3K +909.3K (+100.0%) | 0.07% +0.070 pp | 0.03% +0.030 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 67 | WELLS FARGO & COMPANY/MN | 52.6K +16.3K (+45.0%) | 824.6K +555.7K (+206.7%) | 0.06% +0.020 pp | 0.00% +0.000 pp | USD9.29 +68.8% | 18 qtrs — |
| 68 | MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 49.6K +49.6K (+100.0%) | 778.2K +778.2K (+100.0%) | 0.06% +0.060 pp | 0.00% +0.000 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 69 | STRS OHIO | 36.1K +36.1K (+100.0%) | 566.0K +566.0K (+100.0%) | 0.04% +0.044 pp | 0.00% +0.002 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 70 | VOLORIDGE INVESTMENT MANAGEMENT, LLC | 35.8K +35.8K (+100.0%) | 561.1K +561.1K (+100.0%) | 0.04% +0.043 pp | 0.00% +0.002 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 71 | SIMPLEX TRADING, LLC | 35.1K +2.0K (+6.1%) | 550.7K +305.7K (+124.8%) | 0.04% +0.002 pp | 0.00% +0.000 pp | USD7.88 +99.0% | 4 qtrs — |
| 72 | QUANTINNO CAPITAL MANAGEMENT LP | 33.6K +3.5K (+11.5%) | 526.5K +303.4K (+136.0%) | 0.04% +0.004 pp | 0.00% +0.000 pp | USD6.81 +130.2% | 3 qtrs — |
| 73 | DEUTSCHE BANK AG\ | 33.1K +8.5K (+34.7%) | 519.1K +337.1K (+185.1%) | 0.04% +0.010 pp | 0.00% +0.000 pp | USD10.18 +54.0% | 18 qtrs — |
| 74 | XTX TOPCO LTD | 31.1K -19.0K (-37.9%) | 488.0K +116.6K (+31.4%) | 0.04% -0.023 pp | 0.01% -0.007 pp | USD4.51 +247.7% | 3 qtrs — |
| 75 | AQUATIC CAPITAL MANAGEMENT LLC | 30.9K +30.9K (+100.0%) | 485.1K +485.1K (+100.0%) | 0.04% +0.038 pp | 0.01% +0.014 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 76 | CWM, LLC | 29.4K +3.5K (+13.6%) | 462.0K +270.0K (+140.6%) | 0.04% +0.004 pp | 0.00% +0.001 pp | USD5.87 +167.1% | 5 qtrs — |
| 77 | QUEST PARTNERS LLC | 28.3K +1.1K (+3.9%) | 444.1K +242.2K (+119.9%) | 0.03% +0.001 pp | 0.02% +0.012 pp | USD7.27 +115.7% | 5 qtrs — |
| 78 | ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC | 27.0K +2.4K (+9.6%) | 422.7K +240.4K (+131.9%) | 0.03% +0.003 pp | 0.00% +0.000 pp | USD8.13 +92.9% | 2 qtrs — |
| 79 | VOYA INVESTMENT MANAGEMENT LLC | 26.4K +26.4K (+100.0%) | 413.7K +413.7K (+100.0%) | 0.03% +0.032 pp | 0.00% +0.000 pp | USD15.68 +0.0% | 19 qtrs — |
| 80 | METLIFE INVESTMENT MANAGEMENT, LLC | 26.2K +1.8K (+7.5%) | 410.6K +230.1K (+127.5%) | 0.03% +0.002 pp | 0.00% +0.001 pp | USD6.03 +160.0% | 18 qtrs — |
| 81 | MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 25.6K +4.3K (+20.2%) | 401.8K +244.2K (+155.0%) | 0.03% +0.005 pp | 0.00% +0.000 pp | USD6.41 +144.6% | 7 qtrs — |
| 82 | PROFUND ADVISORS LLC | 25.2K +25.2K (+100.0%) | 395.4K +395.4K (+100.0%) | 0.03% +0.031 pp | 0.01% +0.012 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 83 | NEOS INVESTMENT MANAGEMENT LLC | 25.1K +25.1K (+100.0%) | 394.1K +394.1K (+100.0%) | 0.03% +0.031 pp | 0.00% +0.002 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 84 | TEMA ETFS LLC | 24.8K +24.8K (+100.0%) | 388.3K +388.3K (+100.0%) | 0.03% +0.030 pp | 0.03% +0.030 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 85 | JPMORGAN CHASE & CO | 24.1K +1.2K (+5.1%) | 378.2K +208.2K (+122.5%) | 0.03% +0.001 pp | 0.00% +0.000 pp | USD9.90 +58.4% | 18 qtrs — |
| 86 | CREATIVE PLANNING | 23.4K +23.4K (+100.0%) | 367.0K +367.0K (+100.0%) | 0.03% +0.028 pp | 0.00% +0.000 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 87 | WINTON GROUP LTD | 22.9K +22.9K (+100.0%) | 359.5K +359.5K (+100.0%) | 0.03% +0.028 pp | 0.01% +0.012 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 88 | WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 22.3K +3.7K (+20.2%) | 356.8K +220.0K (+160.8%) | 0.03% +0.005 pp | 0.00% +0.000 pp | USD6.39 +145.4% | 3 qtrs — |
| 89 | LOS ANGELES CAPITAL MANAGEMENT LLC | 26.8K -1.6K (-5.6%) | 348.7K +138.3K (+65.7%) | 0.03% -0.002 pp | 0.00% +0.001 pp | USD5.39 +190.9% | 3 qtrs — |
| 90 | PERSISTENT ASSET PARTNERS LTD | 22.2K +22.2K (+100.0%) | 348.3K +348.3K (+100.0%) | 0.03% +0.027 pp | 0.16% +0.156 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 91 | MARINER, LLC | 21.6K +7.8K (+56.9%) | 339.7K +237.7K (+233.1%) | 0.03% +0.010 pp | 0.00% +0.000 pp | USD8.56 +83.2% | 3 qtrs — |
| 92 | STATE OF WISCONSIN INVESTMENT BOARD | 19.6K -207.0 (-1.0%) | 307.8K +160.8K (+109.4%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD7.21 +117.5% | 15 qtrs — |
| 93 | BROOKWOOD INVESTMENT GROUP LLC | 19.5K +19.5K (+100.0%) | 306.3K +306.3K (+100.0%) | 0.02% +0.024 pp | 0.04% +0.037 pp | USD15.68 +0.0% | 1 qtrs NEW |
| 94 | INTECH INVESTMENT MANAGEMENT LLC | 19.4K +6.0K (+44.7%) | 304.1K +204.7K (+206.1%) | 0.02% +0.007 pp | 0.00% +0.002 pp | USD8.68 +80.6% | 6 qtrs — |
| 95 | CITADEL ADVISORS LLC | 18.7K +8.6K (+85.1%) | 293.2K +218.4K (+291.8%) | 0.02% +0.010 pp | 0.00% +0.000 pp | USD10.03 +56.3% | 13 qtrs — |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 106 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Virtus Biotech Clinical Trials ETF BBC | 0.78% | 447.7K | 0.65% |
| 2 | Global X - S&P Biotech ETF CURE.AX | 0.45% | 162.6K | 0.45% |
| 3 | State Street SPDR S&P Biotech ETF XBI | 0.45% | 48.83M | 0.35% |
| 4 | iShares Micro-Cap ETF IWC | 0.38% | 5.72M | 0.60% |
| 5 | EA Bridgeway Omni Small-Cap Value ETF BSVO | 0.32% | 5.55M | 0.47% |
| 6 | Royce Quant Small-Cap Quality Value ETF SQLV | 0.24% | 70.3K | 0.60% |
| 7 | T. Rowe Price Small-Mid Cap ETF TMSL | 0.22% | 5.94M | 0.55% |
| 8 | T. Rowe Price Innovation Leaders ETF TNXT | 0.21% | 38.9K | 0.49% |
| 9 | First Trust Small Cap Core AlphaDEX Fund FYX | 0.18% | 2.48M | 0.58% |
| 10 | VictoryShares US Small Mid Cap Value Momentum ETF USVM | 0.18% | 3.11M | 0.29% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
1.00
Neutral
Ratio by volume
1.72
Bullish
Buys
2
Sells
2
Shares acquired
23.8K
Shares disposed
13.8K
Cash buys
—
Cash sales
2.00
Net activity
+9,955
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-01 | Warmuth Markus | Director / Officer | S-Sale | D | Common Stock | 5,467 | 18.92 | 103.4K | 600,004 | D | ↗ |
| 2026-04-14 | Warmuth Markus | Director / Officer | S-Sale | D | Common Stock | 8,000 | 17.64 | 141.1K | 605,471 | D | ↗ |
| 2026-04-09 | Nickson Philip | Officer | S-Sale | D | Common Stock | 5,845 | 17.69 | 103.4K | 55,000 | D | ↗ |
| 2026-04-06 | Bowen Matthew | Officer | A-Award | A | Common Stock | 4,300 | 0.00 | — | 25,904 | D | ↗ |
| 2026-04-03 | Bowen Matthew | Officer | — | — | Stock Option (Right to Buy) | 10,800 | 7.11 | 76.8K | 0 | D | ↗ |
| 2026-03-04 | Dunn Edmund | Officer | S-Sale | D | Common Stock | 139 | 17.96 | 2.5K | 22,554 | D | ↗ |
| 2026-03-02 | Warmuth Markus | Director / Officer | S-Sale | D | Common Stock | 5,466 | 17.92 | 98.0K | 613,471 | D | ↗ |
| 2026-03-02 | Dunn Edmund | Officer | M-Exempt | A | Common Stock | 536 | 13.41 | 7.2K | 23,229 | D | ↗ |
| 2026-02-27 | Dunn Edmund | Officer | M-Exempt | A | Common Stock | 25,164 | 13.41 | 337.4K | 47,857 | D | ↗ |
| 2026-02-23 | Janku Filip | Officer | S-Sale | D | Common Stock | 9,189 | 19.50 | 179.2K | 65,837 | D | ↗ |
| 2026-01-07 | Warmuth Markus | Director / Officer | S-Sale | D | Common Stock | 3,707 | 23.24 | 86.2K | 620,696 | D | ↗ |
| 2026-01-05 | Warmuth Markus | Director / Officer | S-Sale | D | Common Stock | 10,135 | 15.17 | 153.7K | 624,403 | D | ↗ |
| 2026-01-05 | Townson Sharon | Officer | S-Sale | D | Common Stock | 3,155 | 15.17 | 47.9K | 67,845 | D | ↗ |
| 2026-01-05 | Nickson Philip | Officer | S-Sale | D | Common Stock | 3,155 | 15.17 | 47.9K | 60,845 | D | ↗ |
| 2026-01-05 | Janku Filip | Officer | S-Sale | D | Common Stock | 3,155 | 15.17 | 47.9K | 75,026 | D | ↗ |
| 2026-01-05 | Dunn Edmund | Officer | S-Sale | D | Common Stock | 1,039 | 15.17 | 15.8K | 22,693 | D | ↗ |
| 2026-01-05 | Champoux Jennifer | Officer | S-Sale | D | Common Stock | 2,629 | 15.17 | 39.9K | 62,371 | D | ↗ |
| 2026-01-02 | Warmuth Markus | Director / Officer | A-Award | A | Common Stock | 90,000 | 0.00 | — | 634,538 | D | ↗ |
| 2026-01-02 | Townson Sharon | Officer | A-Award | A | Stock Option (Right to Buy) | 158,000 | 15.31 | 2.42M | 158,000 | D | ↗ |
| 2026-01-02 | Nickson Philip | Officer | A-Award | A | Common Stock | 28,000 | 0.00 | — | 64,000 | D | ↗ |
| 2026-01-02 | Janku Filip | Officer | A-Award | A | Stock Option (Right to Buy) | 139,000 | 15.31 | 2.13M | 139,000 | D | ↗ |
| 2026-01-02 | Champoux Jennifer | Officer | A-Award | A | Common Stock | 35,000 | 0.00 | — | 65,000 | D | ↗ |
| 2025-06-13 | Skvarka Jan | Director | A-Award | A | Stock Option (Right to Buy) | 30,700 | 4.91 | 150.7K | 30,700 | D | ↗ |
| 2025-06-13 | Siu Christine | Director | A-Award | A | Stock Option (Right to Buy) | 30,700 | 4.91 | 150.7K | 30,700 | D | ↗ |
| 2025-06-13 | SCHIFF ANDREW N | Director | A-Award | A | Stock Option (Right to Buy) | 30,700 | 4.91 | 150.7K | 30,700 | D | ↗ |
| 2025-06-13 | Manning Anthony M. | Director | A-Award | A | Stock Option (Right to Buy) | 30,700 | 4.91 | 150.7K | 30,700 | D | ↗ |
| 2025-06-13 | Hughes Eric A | Director | A-Award | A | Stock Option (Right to Buy) | 30,700 | 4.91 | 150.7K | 30,700 | D | ↗ |
| 2025-06-13 | Blackwell Kimberly | Director | A-Award | A | Stock Option (Right to Buy) | 30,700 | 4.91 | 150.7K | 30,700 | D | ↗ |
| 2025-06-13 | Behbahani Ali | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 30,700 | 4.91 | 150.7K | 30,700 | D | ↗ |
| 2025-06-03 | Dunn Edmund | Officer | S-Sale | D | Common Stock | 2,062 | 4.45 | 9.2K | 23,732 | D | ↗ |
| 2025-03-24 | Leo Chandra P. | Director | P-Purchase | A | Common Stock | 10,000 | 5.84 | 58.4K | 10,000 | D | ↗ |
| 2025-01-02 | Warmuth Markus | Director / Officer | A-Award | A | Common Stock | 128,000 | 0.00 | — | 544,538 | D | ↗ |
| 2025-01-02 | Townson Sharon | Officer | A-Award | A | Common Stock | 36,000 | 0.00 | — | 36,000 | D | ↗ |
| 2025-01-02 | Nickson Philip | Officer | A-Award | A | Common Stock | 36,000 | 0.00 | — | 36,000 | D | ↗ |
| 2025-01-02 | Janku Filip | Officer | A-Award | A | Common Stock | 36,000 | 0.00 | — | 45,189 | D | ↗ |
| 2025-01-02 | Dunn Edmund | Officer | A-Award | A | Common Stock | 11,850 | 0.00 | — | 25,794 | D | ↗ |
| 2025-01-02 | Champoux Jennifer | Officer | A-Award | A | Common Stock | 30,000 | 0.00 | — | 30,000 | D | ↗ |
| 2024-12-11 | Hughes Eric A | Director | A-Award | A | Stock Option (Right to Buy) | 44,200 | 8.51 | 376.1K | 44,200 | D | ↗ |
| 2024-10-29 | Versant Venture Capital VI, L.P. | 10% Owner | S-Sale | D | Common Stock | 52,305 | 9.08 | 475.0K | 1,589,053 | I | ↗ |
| 2024-10-28 | Versant Venture Capital VI, L.P. | 10% Owner | J-Other | D | Common Stock | 5,454 | 0.00 | — | 0 | I | ↗ |
| 2024-09-20 | Versant Venture Capital VI, L.P. | 10% Owner | S-Sale | D | Common Stock | 1,132,566 | 6.53 | 7.40M | 5,099,336 | D | ↗ |
| 2024-09-13 | Versant Venture Capital VI, L.P. | 10% Owner | S-Sale | D | Common Stock | 9,269 | 6.16 | 57.1K | 6,231,902 | — | ↗ |
| 2024-09-13 | Janku Filip | Officer | A-Award | A | Stock Option (Right to Buy) | 30,000 | 7.56 | 226.8K | 30,000 | — | ↗ |
| 2024-09-12 | Versant Venture Capital VI, L.P. | 10% Owner | S-Sale | D | Common Stock | 16,047 | 6.00 | 96.3K | 6,241,171 | — | ↗ |
| 2024-09-11 | Versant Venture Capital VI, L.P. | 10% Owner | S-Sale | D | Common Stock | 541,897 | 6.00 | 3.25M | 6,257,218 | — | ↗ |
| 2024-07-05 | Dunn Edmund | Officer | S-Sale | D | Common Stock | 1,610 | 3.83 | 6.2K | 13,944 | — | ↗ |
| 2024-06-12 | Skvarka Jan | Director | A-Award | A | Stock Option (Right to Buy) | 22,100 | 4.16 | 91.9K | 22,100 | — | ↗ |
| 2024-06-12 | Siu Christine | Director | A-Award | A | Stock Option (Right to Buy) | 22,100 | 4.16 | 91.9K | 22,100 | — | ↗ |
| 2024-06-12 | SCHIFF ANDREW N | Director | A-Award | A | Stock Option (Right to Buy) | 22,100 | 4.16 | 91.9K | 22,100 | — | ↗ |
| 2024-06-12 | Manning Anthony M. | Director | A-Award | A | Stock Option (Right to Buy) | 22,100 | 4.16 | 91.9K | 22,100 | — | ↗ |
| 2024-06-12 | Blackwell Kimberly | Director | A-Award | A | Stock Option (Right to Buy) | 22,100 | 4.16 | 91.9K | 22,100 | — | ↗ |
| 2024-06-12 | Behbahani Ali | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 22,100 | 4.16 | 91.9K | 22,100 | — | ↗ |
| 2024-06-03 | Townson Sharon | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 3.98 | 159.2K | 40,000 | — | ↗ |
| 2024-06-03 | Nickson Philip | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 3.98 | 159.2K | 40,000 | — | ↗ |
| 2024-06-03 | Dunn Edmund | Officer | S-Sale | D | Common Stock | 1,207 | 4.04 | 4.9K | 15,554 | — | ↗ |
| 2024-06-03 | Champoux Jennifer | Officer | A-Award | A | Stock Option (Right to Buy) | 40,000 | 3.98 | 159.2K | 40,000 | — | ↗ |
| 2024-05-28 | Townson Sharon | Officer | — | D | Stock Option (Right to Buy) | 215,290 | 6.14 | 1.32M | 0 | — | ↗ |
| 2024-05-28 | Champoux Jennifer | Officer | — | D | Stock Option (Right to Buy) | 79,000 | 5.71 | 451.1K | 0 | — | ↗ |
| 2024-01-02 | Warmuth Markus | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 346,000 | 5.71 | 1.98M | 346,000 | — | ↗ |
| 2024-01-02 | Wallace Owen B. | Officer | A-Award | A | Stock Option (Right to Buy) | 119,000 | 5.71 | 679.5K | 119,000 | — | ↗ |
| 2024-01-02 | Nickson Philip | Officer | A-Award | A | Stock Option (Right to Buy) | 109,000 | 5.71 | 622.4K | 109,000 | — | ↗ |
| 2024-01-02 | Jones Jullian G | Officer | A-Award | A | Stock Option (Right to Buy) | 79,000 | 5.71 | 451.1K | 79,000 | — | ↗ |
| 2024-01-02 | Janku Filip | Officer | A-Award | A | Stock Option (Right to Buy) | 121,000 | 5.71 | 690.9K | 121,000 | — | ↗ |
| 2024-01-02 | Dunn Edmund | Officer | A-Award | A | Stock Option (Right to Buy) | 35,900 | 5.71 | 205.0K | 35,900 | — | ↗ |
| 2023-08-08 | Dunn Edmund | Officer | — | D | Common Stock | 0 | 0.00 | — | 16,761 | — | ↗ |
| 2023-07-25 | Manning Anthony M. | Director | A-Award | A | Stock Option (Right to Buy) | 41,000 | 6.70 | 274.7K | 41,000 | — | ↗ |
| 2023-06-14 | Skvarka Jan | Director | A-Award | A | Stock Option (Right to Buy) | 20,500 | 6.59 | 135.1K | 20,500 | — | ↗ |
| 2023-06-14 | Siu Christine | Director | A-Award | A | Stock Option (Right to Buy) | 20,500 | 6.59 | 135.1K | 20,500 | — | ↗ |
| 2023-06-14 | SCHIFF ANDREW N | Director | A-Award | A | Stock Option (Right to Buy) | 20,500 | 6.59 | 135.1K | 20,500 | — | ↗ |
| 2023-06-14 | Mayweg Alexander | Director | A-Award | A | Stock Option (Right to Buy) | 20,500 | 6.59 | 135.1K | 20,500 | — | ↗ |
| 2023-06-14 | Blackwell Kimberly | Director | A-Award | A | Stock Option (Right to Buy) | 20,500 | 6.59 | 135.1K | 20,500 | — | ↗ |
| 2023-06-14 | Behbahani Ali | Director / 10% Owner | A-Award | A | Stock Option (Right to Buy) | 20,500 | 6.59 | 135.1K | 20,500 | — | ↗ |
| 2023-03-30 | Skvarka Jan | Director | A-Award | A | Stock Option (Right to Buy) | 41,000 | 7.36 | 301.8K | 41,000 | — | ↗ |
| 2023-03-23 | Skvarka Jan | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-01-03 | Warmuth Markus | Officer | A-Award | A | Stock Option (Right to Buy) | 472,000 | 0.00 | — | 472,000 | — | ↗ |
| 2023-01-03 | Wallace Owen B. | Officer | A-Award | A | Stock Option (Right to Buy) | 135,000 | 0.00 | — | 135,000 | — | ↗ |
| 2023-01-03 | Townson Sharon | Officer | A-Award | A | Stock Option (Right to Buy) | 78,550 | 0.00 | — | 78,550 | — | ↗ |
| 2023-01-03 | Tamboli Ajim | Officer | A-Award | A | Stock Option (Right to Buy) | 129,850 | 0.00 | — | 129,850 | — | ↗ |
| 2023-01-03 | Nickson Philip | Officer | A-Award | A | Stock Option (Right to Buy) | 123,650 | 0.00 | — | 123,650 | — | ↗ |
| 2023-01-03 | Jones Jullian G | Officer | A-Award | A | Stock Option (Right to Buy) | 77,450 | 0.00 | — | 77,450 | — | ↗ |
| 2023-01-03 | Janku Filip | Officer | A-Award | A | Stock Option (Right to Buy) | 135,000 | 0.00 | — | 135,000 | — | ↗ |
| 2023-01-03 | Castle John C. | Officer | A-Award | A | Stock Option (Right to Buy) | 78,500 | 0.00 | — | 78,500 | — | ↗ |
| 2022-12-15 | Janku Filip | Officer | A-Award | A | Stock Option (Right to Buy) | 36,000 | 0.00 | — | 36,000 | — | ↗ |
| 2022-10-31 | Janku Filip | Officer | A-Award | A | Stock Option (Right to Buy) | 36,000 | 0.00 | — | 36,000 | — | ↗ |
| 2022-06-15 | Siu Christine | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | SCHIFF ANDREW N | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | Mayweg Alexander | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-06-15 | Blackwell Kimberly | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 7.66 | 114.9K | 15,000 | — | ↗ |
| 2022-06-15 | Behbahani Ali | Director | A-Award | A | Stock Option (Right to Buy) | 15,000 | 0.00 | — | 15,000 | — | ↗ |
| 2022-03-01 | Warmuth Markus | Officer | A-Award | A | Stock Option (Right to Buy) | 315,600 | 0.00 | — | 315,600 | — | ↗ |
| 2022-03-01 | Wallace Owen B. | Officer | A-Award | A | Stock Option (Right to Buy) | 117,450 | 13.41 | 1.58M | 117,450 | — | ↗ |
| 2022-03-01 | Townson Sharon | Officer | A-Award | A | Stock Option (Right to Buy) | 70,000 | 13.41 | 938.7K | 70,000 | — | ↗ |
| 2022-03-01 | Tamboli Ajim | Officer | A-Award | A | Stock Option (Right to Buy) | 111,700 | 13.41 | 1.50M | 111,700 | — | ↗ |
| 2022-03-01 | Nickson Philip | Officer | — | D | Stock Option (Right to Buy) | 50,974 | 19.00 | 968.5K | 0 | — | ↗ |
| 2022-03-01 | Jones Jullian G | Officer | A-Award | A | Stock Option (Right to Buy) | 73,300 | 0.00 | — | 73,300 | — | ↗ |
| 2022-03-01 | Janku Filip | Officer | A-Award | A | Stock Option (Right to Buy) | 86,500 | 13.41 | 1.16M | 86,500 | — | ↗ |
| 2022-03-01 | Castle John C. | Officer | A-Award | A | Stock Option (Right to Buy) | 53,700 | 13.41 | 720.1K | 53,700 | — | ↗ |
| 2021-12-01 | Jones Julian G | Officer | — | D | Stock Option Grant (Right to Buy) | 187,225 | 2.19 | 410.0K | 0 | — | ↗ |
| 2021-06-28 | Yang Rick | 10% Owner | C-Conversion | D | Series B convertible preferred stock | 11,500,000 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | Walker Paul Edward | 10% Owner | P-Purchase | A | Common Stock | 1,050,000 | 19.00 | 19.95M | 7,692,298 | — | ↗ |
| 2021-06-28 | Versant Venture Capital VI, L.P. | 10% Owner | C-Conversion | D | Series A convertible preferred stock | 20,004,280 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | Sonsini Peter W. | 10% Owner | C-Conversion | A | Common Stock | 669,002 | 0.00 | — | 6,642,298 | — | ↗ |
| 2021-06-28 | SANDELL SCOTT D | 10% Owner | C-Conversion | D | Series C convertible preferred Stock | 2,361,912 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | New Enterprise Associates 17, L.P. | Director | C-Conversion | A | Common Stock | 669,002 | 0.00 | — | 6,642,298 | — | ↗ |
| 2021-06-28 | Mathers Edward T | 10% Owner | P-Purchase | A | Common Stock | 1,050,000 | 19.00 | 19.95M | 7,692,298 | — | ↗ |
| 2021-06-28 | Makhzoumi Mohamad | 10% Owner | C-Conversion | D | Series B convertible preferred stock | 11,500,000 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | MAKOWER JOSHUA | 10% Owner | C-Conversion | A | Common Stock | 3,257,328 | 0.00 | — | 5,973,296 | — | ↗ |
| 2021-06-28 | Landsman Liza | 10% Owner | C-Conversion | A | Common Stock | 669,002 | 0.00 | — | 6,642,298 | — | ↗ |
| 2021-06-28 | Florence Anthony A. Jr. | 10% Owner | C-Conversion | D | Series B convertible preferred stock | 11,500,000 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | Cormorant Asset Management, LP | — | C-Conversion | A | Series B Convertible Preferred Stock | 2,124,343 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | Chang Carmen | 10% Owner | C-Conversion | D | Series C convertible preferred Stock | 2,361,912 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | Bolzon Bradley J PhD | Director / 10% Owner | C-Conversion | D | Series C convertible preferred stock | 2,699,328 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | Behbahani Ali | Director / 10% Owner | C-Conversion | D | Series B convertible preferred stock | 11,500,000 | 0.00 | — | 0 | — | ↗ |
| 2021-06-28 | BASKETT FOREST | 10% Owner | C-Conversion | D | Series A-2 convertible preferred stock | 9,588,725 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Yang Rick | 10% Owner | — | I | Series B convertible preferred stock | 3,257,328 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Warmuth Markus | Director / Officer | — | D | Stock Option (Right to Buy) | 538,517 | 6.14 | 3.31M | 0 | — | ↗ |
| 2021-06-23 | Wallace Owen B. | Officer | — | D | Stock Option (Right to Buy) | 387,069 | 6.14 | 2.38M | 0 | — | ↗ |
| 2021-06-23 | Walker Paul Edward | 10% Owner | — | I | Series A-2 convertible preferred stock | 2,715,968 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Versant Venture Capital VI, L.P. | 10% Owner | — | D | Series A convertible preferred stock | 5,666,131 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Townson Sharon | Officer | — | D | Stock Option (Right to Buy) | 75,011 | 1.13 | 84.8K | 0 | — | ↗ |
| 2021-06-23 | Tamboli Ajim | Officer | — | D | Stock Option (Right to Buy) | 100,938 | 6.14 | 619.8K | 0 | — | ↗ |
| 2021-06-23 | Sonsini Peter W. | 10% Owner | — | I | Series A-2 convertible preferred stock | 2,715,968 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Siu Christine | Director | — | D | Stock Option (Right to Buy) | 7,081 | 6.14 | 43.5K | 0 | — | ↗ |
| 2021-06-23 | SCHIFF ANDREW N | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | SANDELL SCOTT D | 10% Owner | — | I | Series B convertible preferred stock | 3,257,328 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Mayweg Alexander | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Mathers Edward T | 10% Owner | — | I | Series B convertible preferred stock | 3,257,328 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Makhzoumi Mohamad | 10% Owner | — | I | Series B convertible preferred stock | 3,257,328 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | MAKOWER JOSHUA | 10% Owner | — | I | Series C convertible preferred stock | 669,002 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Leo Chandra P. | Director | A-Award | A | Stock Option (Right to Buy) | 47,132 | 19.00 | 895.5K | 47,132 | — | ↗ |
| 2021-06-23 | Landsman Liza | 10% Owner | — | I | Series C convertible preferred stock | 669,002 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Janku Filip | Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Florence Anthony A. Jr. | 10% Owner | — | I | Series A-2 convertible preferred stock | 2,715,968 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Cormorant Asset Management, LP | 10% Owner | — | I | Series C Convertible Preferred Stock | 477,857 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Chang Carmen | 10% Owner | — | I | Series C convertible preferred stock | 669,002 | 0.00 | — | 0 | — | ↗ |
| 2021-06-23 | Bolzon Bradley J PhD | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 283,246 | — | ↗ |
| 2021-06-23 | Blackwell Kimberly | Director | — | D | Stock Option (Right to Buy) | 7,081 | 6.14 | 43.5K | 0 | — | ↗ |
| 2021-06-23 | Behbahani Ali | Director / 10% Owner | — | I | Series A-2 convertible preferred stock | 2,715,968 | 0.00 | — | 0 | — | ↗ |
| 2021-04-12 | Warmuth Markus | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 538,517 | 6.14 | 3.31M | 538,517 | — | ↗ |
| 2021-04-12 | Wallace Owen B. | Officer | A-Award | A | Stock Option (Right to Buy) | 387,069 | 6.14 | 2.38M | 387,069 | — | ↗ |
| 2021-04-12 | Tamboli Ajim | Officer | A-Award | A | Stock Option (Right to Buy) | 100,938 | 6.14 | 619.8K | 100,938 | — | ↗ |
| 2021-04-12 | Siu Christine | Director | A-Award | A | Stock Option (Right to Buy) | 7,081 | 6.14 | 43.5K | 7,081 | — | ↗ |
| 2021-04-12 | Blackwell Kimberly | Director | A-Award | A | Stock Option (Right to Buy) | 7,081 | 6.14 | 43.5K | 7,081 | — | ↗ |
| 2021-03-11 | Bolzon Bradley J PhD | Director / 10% Owner | A-Award | A | Series C convertible preferred stock | 2,699,328 | 0.00 | — | 2,699,328 | — | ↗ |
| 2021-02-24 | Bolzon Bradley J PhD | Director / 10% Owner | A-Award | A | Series B convertible preferred stock | 2,075,000 | 0.00 | — | 4,150,000 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-381.7K
Shares Outstanding
65.12M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2025 | Markus Warmuth, M.D. Chief Executive Officer | 650.0K | — | 910.1K | 3.04M | 429.0K | — | 5.03M | 78.56% | ↗ |
| 2 | 2025 | Phil Nickson, Ph.D. Chief Business and Legal Officer | 520.0K | — | 256.0K | 852.2K | 299.6K | 14.0K | 1.94M | 57.07% | ↗ |
| 3 | 2025 | Filip Janku, M.D., Ph.D. Chief Medical Officer | 520.0K | — | 256.0K | 852.2K | 299.6K | 14.0K | 1.94M | 57.07% | ↗ |
| 4 | 2024 | Markus Warmuth, M.D. Chief Executive Officer | 616.4K | — | — | 1.47M | 354.4K | — | 2.44M | 60.23% | ↗ |
| 5 | 2024 | Phil Nickson, Ph.D. Chief Business and Legal Officer | 473.6K | — | — | 582.8K | 217.4K | 13.8K | 1.29M | 45.26% | ↗ |
| 6 | 2024 | Filip Janku, M.D., Ph.D. Chief Medical Officer | 500.0K | — | — | 514.1K | 230.0K | 13.8K | 1.26M | 40.87% | ↗ |
| 7 | 2023 | Markus Warmuth, M.D. Chief Executive Officer | 616.4K | — | — | 2.70M | 308.2K | — | 3.63M | 74.51% | ↗ |
| 8 | 2023 | Filip Janku, M.D., Ph.D. Chief Medical Officer | 500.0K | — | — | 773.0K | 200.0K | 13.2K | 1.49M | 52.01% | ↗ |
| 9 | 2023 | Owen Wallace, Ph.D. Chief Scientific Officer | 451.0K | — | — | 773.0K | 180.4K | 13.2K | 1.42M | 54.53% | ↗ |
| 10 | 2023 | Phil Nickson, Ph.D. Chief Business and Legal Officer | 432.0K | — | — | 708.0K | 172.8K | 13.2K | 1.33M | 53.39% | ↗ |
| 11 | 2022 | Markus Warmuth, M.D. Chief Executive Officer | 581.5K | — | — | 2.91M | 319.8K | — | 3.81M | 76.34% | ↗ |
| 12 | 2022 | Filip Janku, M.D., Ph.D. Chief Medical Officer | 436.8K | — | — | 1.39M | 209.7K | 12.2K | 2.05M | 67.79% | ↗ |
| 13 | 2022 | Owen Wallace, Ph.D. Chief Scientific Officer | 429.5K | — | — | 1.08M | 189.0K | 12.2K | 1.71M | 63.18% | ↗ |
| 14 | 2021 | Filip Janku, M.D., Ph.D. Chief Medical Officer | 236.9K | 105.5K | — | 5.00M | — | 8.6K | 5.35M | 93.44% | ↗ |
| 15 | 2021 | Markus Warmuth, M.D. Chief Executive Officer | 525.4K | 317.6K | — | 4.11M | — | — | 4.95M | 82.98% | ↗ |
| 16 | 2021 | Owen Wallace, Ph.D. Chief Scientific Officer | 376.1K | 168.0K | — | 3.10M | — | 11.6K | 3.65M | 84.78% | ↗ |
| 17 | 2020 | Markus Warmuth, M.D. Chief Executive Officer | 465.0K | 434.2K | 191.0K | 1.13M | — | — | 2.22M | 59.51% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Markus Warmuth | President, Chief Executive Officer & Director | 970.8K | — |
| Filip Janku | Chief Medical Officer | 833.6K | male |
| Phil Nickson | Chief Business & Legal Officer | 833.6K | male |
| Sharon Townson | Chief Scientific Officer | 644.6K | — |
| Andrew Funderburk | Chief Investor Relations and Strategy Officer | — | male |
| Matthew Bowen | Corporate Controller & Principal Accounting Officer | — | male |
| Magnus Walter DPHIL | Chief Technology Officer | — | male |
| Edmund Dunn | Senior Vice President & Corporate Controller | — | male |
| Jennifer Champoux | Chief Operating Officer | — | female |
| John C. Castle | Chief Data & Information Officer | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GLUE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
